BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 30302057)

  • 1. Conserved cell populations in doxorubicin-resistant human nasal natural killer/T cell lymphoma cell line: super multidrug resistant cells?
    Zhang X; Fu X; Dong M; Yang Z; Wu S; Ma M; Li Z; Wang X; Li L; Li X; Sun Z; Chang Y; Nan F; Yan J; Mao Y; Zhang M; Chen Q
    Cancer Cell Int; 2018; 18():150. PubMed ID: 30302057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-6 reverses Adriamycin resistance in nasal NK/T-cell lymphoma via downregulation of ABCC4 and inactivation of the JAK2/STAT3/NF-κB/P65 pathway.
    Gao M; Liu L; Zhang X; Li Z; Zhang M
    Environ Toxicol Pharmacol; 2021 Jul; 85():103639. PubMed ID: 33771682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Icaritin induces lytic cytotoxicity in extranodal NK/T-cell lymphoma.
    Wu T; Wang S; Wu J; Lin Z; Sui X; Xu X; Shimizu N; Chen B; Wang X
    J Exp Clin Cancer Res; 2015 Feb; 34(1):17. PubMed ID: 25887673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ATP-binding cassette sub-family C member 4 (ABCC4) is overexpressed in human NK/T-cell lymphoma and regulates chemotherapy sensitivity: Potential as a functional therapeutic target.
    Zhang X; Zhao L; Li X; Wang X; Li L; Fu X; Sun Z; Li Z; Nan F; Chang Y; Zhang M
    Leuk Res; 2015 Dec; 39(12):1448-54. PubMed ID: 26499190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-13 Contributes to Drug Resistance of NK/T-Cell Lymphoma Cells by Regulating ABCC4.
    Ni M; Qin B; Xie L; Zhang X; Yang J; Lv H; Yang M; Zhang M
    Biomed Res Int; 2018; 2018():2606834. PubMed ID: 30643796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus-associated natural killer/T-cell lymphomas.
    Asano N; Kato S; Nakamura S
    Best Pract Res Clin Haematol; 2013 Mar; 26(1):15-21. PubMed ID: 23768637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of programmed death ligands in effective T-cell interactions in extranodal natural killer/T-cell lymphoma.
    Han L; Liu F; Li R; Li Z; Chen X; Zhou Z; Zhang X; Hu T; Zhang Y; Young K; Sun S; Wen J; Zhang M
    Oncol Lett; 2014 Oct; 8(4):1461-1469. PubMed ID: 25202350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DDGP vs. SMILE in Relapsed/Refractory Extranodal Natural Killer/T-cell Lymphoma, Nasal Type: A Retrospective Study of 54 Patients.
    Wang X; Hu J; Dong M; Ding M; Zhu L; Wu J; Sun Z; Li X; Zhang L; Li L; Wang X; Fu X; Wang G; Chen Q; Zhang M; Zhang X
    Clin Transl Sci; 2021 Jan; 14(1):405-411. PubMed ID: 33045134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Common cytological and cytogenetic features of Epstein-Barr virus (EBV)-positive natural killer (NK) cells and cell lines derived from patients with nasal T/NK-cell lymphomas, chronic active EBV infection and hydroa vacciniforme-like eruptions.
    Zhang Y; Nagata H; Ikeuchi T; Mukai H; Oyoshi MK; Demachi A; Morio T; Wakiguchi H; Kimura N; Shimizu N; Yamamoto K
    Br J Haematol; 2003 Jun; 121(5):805-14. PubMed ID: 12780797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of refractory/relapsed extranodal NK/T cell lymphoma with decitabine plus anti-PD-1: A case report.
    Li LJ; Zhang JY
    World J Clin Cases; 2022 Oct; 10(28):10193-10200. PubMed ID: 36246799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-2Rα up-regulation is mediated by latent membrane protein 1 and promotes lymphomagenesis and chemotherapy resistance in natural killer/T-cell lymphoma.
    Wang L; Bi XW; Zhu YJ; He YZ; Lai QY; Xia ZJ; Cai QQ
    Cancer Commun (Lond); 2018 Oct; 38(1):62. PubMed ID: 30340635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NK/T Cell Lymphoma: Updates in Therapy.
    Suzuki R
    Curr Hematol Malig Rep; 2018 Feb; 13(1):7-12. PubMed ID: 29368155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ABCG2 gene amplification and expression in esophageal cancer cells with acquired adriamycin resistance.
    Liu L; Zuo LF; Guo JW
    Mol Med Rep; 2014 Apr; 9(4):1299-304. PubMed ID: 24535197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PD-L1 is upregulated by EBV-driven LMP1 through NF-κB pathway and correlates with poor prognosis in natural killer/T-cell lymphoma.
    Bi XW; Wang H; Zhang WW; Wang JH; Liu WJ; Xia ZJ; Huang HQ; Jiang WQ; Zhang YJ; Wang L
    J Hematol Oncol; 2016 Oct; 9(1):109. PubMed ID: 27737703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HOXB4 knockdown reverses multidrug resistance of human myelogenous leukemia K562/ADM cells by downregulating P-gp, MRP1 and BCRP expression via PI3K/Akt signaling pathway.
    Wang H; Jia XH; Chen JR; Yi YJ; Wang JY; Li YJ; Xie SY
    Int J Oncol; 2016 Dec; 49(6):2529-2537. PubMed ID: 27779650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current treatment approaches for NK/T-cell lymphoma.
    Yamaguchi M; Miyazaki K
    J Clin Exp Hematop; 2017 Dec; 57(3):98-108. PubMed ID: 28679966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis and treatment of extranodal natural killer/T-cell lymphoma.
    Suzuki R
    Semin Hematol; 2014 Jan; 51(1):42-51. PubMed ID: 24468315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of doxorubicin on TRAIL resistance and TRAIL receptor expression in lymphoma cell line SNK-6 cells].
    Zhang YC; Yang QP; Tang Y; Wang WY; Yu JB; Liu WP
    Zhonghua Zhong Liu Za Zhi; 2013 Sep; 35(9):651-4. PubMed ID: 24332050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of interleukin-9 in nasal natural killer/T-cell lymphoma cell lines and patients.
    Nagato T; Kobayashi H; Kishibe K; Takahara M; Ogino T; Ishii H; Oikawa K; Aoki N; Sato K; Kimura S; Shimizu N; Tateno M; Harabuchi Y
    Clin Cancer Res; 2005 Dec; 11(23):8250-7. PubMed ID: 16322282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Features and Current Optimal Management of Natural Killer/T-Cell Lymphoma.
    Makita S; Tobinai K
    Hematol Oncol Clin North Am; 2017 Apr; 31(2):239-253. PubMed ID: 28340876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.